Lundbeck
HLUN-B.CO
#2592
Rank
โ‚น654.46 B
Marketcap
โ‚น659.64
Share price
0.74%
Change (1 day)
5.23%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): โ‚น69.37

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น72.44. In 2025 the company made an earnings per share (EPS) of โ‚น48.25 an increase over its 2024 EPS that were of โ‚น42.14.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น69.3743.77%
2025โ‚น48.2514.5%
2024โ‚น42.1429.29%
2023โ‚น32.5923.09%
2022โ‚น26.4837.26%
2021โ‚น19.29-84.61%
2020โ‚น125.35-24.61%
2019โ‚น166.26-42.06%
2018โ‚น286.9540.7%
2017โ‚น203.95146.26%
2016โ‚น82.82-120.48%
2015-โ‚น404.303231.32%
2014-โ‚น12.14-115.78%
2013โ‚น76.90-23.36%
2012โ‚น100.34-48.01%
2011โ‚น193.01-9.68%
2010โ‚น213.7113.72%
2009โ‚น187.9224.32%
2008โ‚น151.16-6.05%
2007โ‚น160.8981.77%
2006โ‚น88.51-16.76%
2005โ‚น106.34-17.58%
2004โ‚น129.03